These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 10049059)
1. Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival. Gupta P; Niehans GA; LeRoy SC; Gupta K; Morrison VA; Schultz C; Knapp DJ; Kratzke RA Leukemia; 1999 Jan; 13(1):44-53. PubMed ID: 10049059 [TBL] [Abstract][Full Text] [Related]
2. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438 [TBL] [Abstract][Full Text] [Related]
3. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome]. Zhang Z; Xie J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412 [TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count. Chan GC; Wang WC; Raimondi SC; Behm FG; Krance RA; Chen G; Freiberg A; Ingram L; Butler D; Head DR Leukemia; 1997 Feb; 11(2):206-11. PubMed ID: 9009082 [TBL] [Abstract][Full Text] [Related]
5. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia. Kitagawa M; Yamaguchi S; Takahashi M; Tanizawa T; Hirokawa K; Kamiyama R Leukemia; 1998 Apr; 12(4):486-92. PubMed ID: 9557605 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome. Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690 [TBL] [Abstract][Full Text] [Related]
7. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry. Kanter-Lewensohn L; Hellström-Lindberg E; Kock Y; Elmhorn-Rosenborg A; Ost A Eur J Haematol; 1996 Mar; 56(3):124-9. PubMed ID: 8598230 [TBL] [Abstract][Full Text] [Related]
8. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients. Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149 [TBL] [Abstract][Full Text] [Related]
9. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis. Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260 [TBL] [Abstract][Full Text] [Related]
10. Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis. Lickliter JD; Kratzke RA; Nguyen PL; Niehans GA; Miller JS Exp Hematol; 1999 Oct; 27(10):1519-27. PubMed ID: 10517493 [TBL] [Abstract][Full Text] [Related]
11. Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia. Lewis NR; Pallis M; Russell NH Exp Hematol; 2000 May; 28(5):535-42. PubMed ID: 10812243 [TBL] [Abstract][Full Text] [Related]
12. Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias. Amin HM; Yang Y; Shen Y; Estey EH; Giles FJ; Pierce SA; Kantarjian HM; O'Brien SM; Jilani I; Albitar M Leukemia; 2005 Sep; 19(9):1567-72. PubMed ID: 16049515 [TBL] [Abstract][Full Text] [Related]
13. Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukaemia. van Lom K; Hagemeijer A; Vandekerckhove F; Smit EM; Löwenberg B Br J Haematol; 1996 Jun; 93(3):594-600. PubMed ID: 8652379 [TBL] [Abstract][Full Text] [Related]
15. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis. Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227 [TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome. Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368 [TBL] [Abstract][Full Text] [Related]
17. Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy. Radujkovic A; Dietrich S; Andrulis M; Benner A; Longerich T; Pellagatti A; Nanda K; Giese T; Germing U; Baldus S; Boultwood J; Ho AD; Dreger P; Luft T Int J Cancer; 2016 Sep; 139(6):1402-13. PubMed ID: 27170453 [TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of the Fas receptor and its ligand in adult human bone marrow: a regulatory feedback loop for the homeostatic control of hematopoiesis. Brazil JJ; Gupta P Blood Cells Mol Dis; 2002; 29(1):94-103. PubMed ID: 12482410 [TBL] [Abstract][Full Text] [Related]
19. [An evaluation of the prognostic significance of antigen CD95(Fas/APO-1) expression on the cells of patients with a myelodysplastic syndrome, acute myeloid leukemia and chronic myeloleukemia]. Polosukhina ER; Kuznetsov SV; Logcheva NP; Zabotina TN; Tenuta MR; Shirin AD; Kaletin GI; Turkina AG; Tsvetaeva NV; Shishkin IuV; Kadagidze ZG; Khoroshko ND; Volkova MA; Baryshnikov AIu Ter Arkh; 1998; 70(7):21-5. PubMed ID: 9742630 [TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes. Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]